Publicacións nas que colabora con Ignacio García Talavera (18)

2024

  1. Oxygen therapy could improve survival in patients with early desaturation in the 6-minute walk test: A post hoc analysis

    Respirology

2023

  1. Classification of the Severity of COPD Exacerbations in Hospitalized Patients According to Rome vs GesEPOC Criteria

    Archivos de Bronconeumologia, Vol. 59, Núm. 1, pp. 57-58

  2. Early Desaturation During 6-Minute Walk Test is a Predictor of Mortality in COPD

    Lung, Vol. 201, Núm. 2, pp. 217-224

  3. Relationship Between the Summation of GesEPOC High-Risk Factors and the Presence of Cardiovascular Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 6, pp. 403-405

2022

  1. A new, three-dimensional approach to the GOLD COPD assessment tool

    Respiratory Medicine and Research, Vol. 81

  2. Evaluation of the multimorbidity network and its relationship with clinical phenotypes in chronic obstructive pulmonary disease: The GALAXIA study

    Clinical Respiratory Journal, Vol. 16, Núm. 7, pp. 504-512

  3. Relationship Between the GesEPOC 2021 Classification of Risk Levels and Phenotypes and the Incidence of Adverse Events

    Archivos de Bronconeumologia, Vol. 58, Núm. 5, pp. 451-453

  4. Trajectories of Severe Exacerbations of Chronic Obstructive Pulmonary Disease and Their Relationship with Mortality Risk

    Lung, Vol. 200, Núm. 5, pp. 601-607

2021

  1. Initial Treatment in Chronic Obstructive Pulmonary Disease According to GesEPOC 2021 vs. GesEPOC 2017. Approaching Criteria with GOLD 2021?

    Archivos de Bronconeumologia

  2. Post-COVID syndrome in the patient with chronic obstructive pulmonary disease: A Trojan horse?

    Semergen

  3. Should pulse oximeter saturations be included in the risk stratification for chronic obstructive pulmonary disease proposed by GesEPOC?

    Archivos de Bronconeumologia

  4. Síndrome post-COVID en el paciente con enfermedad pulmonar obstructiva crónica: ¿Un caballo de Troya?

    Semergen: revista española de medicina de familia, Núm. 2, pp. 136-137

2020

  1. Chronic Obstructive Pulmonary Disease and SARS-CoV-2 Infection. What Do We Know so Far?

    Archivos de Bronconeumologia

  2. Impact of diabetes mellitus on the risk of severe exacerbation in patients with chronic obstructive pulmonary disease

    Clinical Respiratory Journal, Vol. 14, Núm. 12, pp. 1208-1211

  3. Should Pulse Oximeter Saturations Be Included in the Risk Stratification for Chronic Obstructive Pulmonary Disease Proposed by GesEPOC?

    Archivos de Bronconeumologia

2019

  1. Can the COPD-comorbidome Be Applied to All Outpatients With Chronic Obstructive Pulmonary Disease? A Single-center Analysis

    Archivos de Bronconeumologia, Vol. 55, Núm. 11, pp. 591-593

  2. Comparison of the prognostic capability of two comorbidity indices in patients with chronic obstructive pulmonary disease, in real-life clinical practice

    Clinical Respiratory Journal, Vol. 13, Núm. 6, pp. 404-407

2007

  1. Impacto de la EPOC en la vida diaria de los pacientes. Resultados del estudio multicéntrico EIME

    Archivos de Bronconeumologia, Vol. 43, Núm. 2, pp. 64-72